News · 18 November 2026

US-backed hepatitis B vaccine trial on African newborns is halted

18 November 2026 · World · Health · Science

US-backed hepatitis B vaccine trial on African newborns is halted
Picture: Guardian World · Guardian World syndication feed

A US-backed hepatitis B vaccine trial on newborns in Guinea-Bissau will not go ahead. Lead researcher Frederik Schaltz-Buchholzer said the team did not get government approval. The study would have kept the vaccine from some babies, which experts called unethical. The CDC had pledged $1.6 million. On Monday, police searched the researchers' offices and seized vaccine doses.

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026